AtheroGenics up on 2Q news
Share prices for AtheroGenics Inc. (NASDAQ: AGIX) rose 16 percent today to $1.30, thanks largely to the company's recent second quarter 2007 results.According to the latest company statement, AtheroGenics recorded revenue of $30.3 million for the second quarter of 2007, an amazing $24 million increase over the same period for 206. The figures for the six-month period ending June 30, 2007, were also impressive, as the company reported that their revenues increased from $10.4 million last year to $41.7 million this year. The company attributed both these increases to "the recognition of the remaining unamortized balance of an upfront license…